The event is real and documented on official institutional channels. UCLH states that Rhys Hibbert, aged 48 from Bedfordshire, a customer services manager, is the first patient to have surgery in this way, that without surgery his tumour would have continued to threaten his sight and could ultimately have led to blindness, and that the operation successfully removed the tumour and protected his vision.

UCLH describes the system as analysing the live surgical video feed in real time, rather than using pre-surgery scans, to help the surgical team make more precise decisions by highlighting critical structures at the base of the brain. UCL states the operation was carried out at the National Hospital for Neurology and Neurosurgery, UCLH, as part of a clinical trial using AI technology developed in-house at UCL and funded by the National Institute for Health and Care Research.

UCL also states the AI learned from hundreds of surgical videos and is designed to help recognise critical anatomy, surgical instruments and tissue interactions.

Professor Hani Marcus, UCL Queen Square Institute of Neurology and consultant neurosurgeon at NHNN, performed the surgery alongside Danyal Khan, a UCL PhD candidate and neurosurgical resident leading the work.

The underlying research artifact exists and is more specific than the press coverage. The preprint reports that eight patients with pituitary adenomas were enrolled, the system was successfully deployed in six cases demonstrating acceptable real-time pixel-level sella segmentation accuracy, and deployment failed pre-operatively in two cases owing to a single recurring system reboot bug.

Iterative refinement resulted in the integration of additional anatomical structure segmentations such as carotid arteries, enhanced model accuracy via training dataset expansion, and hardware firmware upgrades, and both prospective observation and retrospective video review confirmed the absence of adverse events, including no significant distraction to the primary surgeon and no AI-related clinical complications.

The model used a DINOv3-derived vision transformer architecture, deployed via a high-performance edge computing unit for low-latency real-time inference without cloud infrastructure.

On the "first" claim, the team's own literature search is the basis. The preprint states that a search of PubMed and Embase found prospective clinical evaluation of computer vision segmentation for intra-operative navigation only in general surgery, with no published real-time AI anatomical navigation in neurosurgery, and describes the study as the first clinical evaluation of real-time CVAI anatomical navigation in neurosurgery. UCLH itself scopes the novelty rather than claiming AI in surgery is new: it notes other researchers worldwide have explored AI support in neurosurgery in real time, including using AI to highlight tumour tissue on intraoperative ultrasound or to flag the approximate location of important structures during surgery, and frames the new question as whether AI can provide useful real-time assistance and whether doing so is safe.

Patient-level details in the post check out against reporting. A brain scan revealed an 11mm non-cancerous tumour on the pituitary gland, which sits very close to the carotid arteries and the optic nerves that control vision, and as the tumour pressed on his optic nerves it narrowed his peripheral vision.

Hibbert said "When I came round... I could see everything in the room clearly," and after roughly one week he could walk independently without assistance or glasses, with the surgery performed in May.

The tool was designed in-house at UCL's Hawkes Institute and runs on NVIDIA's Clara IGX computer.

The team emphasised that this was not autonomous surgery and that the surgeons could interpret or disregard the information the system produced.